MoneyWorks4Me

Parmax Pharma informs about board meeting

23 Jun 2021 Evaluate

Pursuant to Regulation 29(1) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parmax Pharma has informed that a meeting of the Board of Directors of the Company is proposed to be held on Tuesday, the 29th June, 2021 at 4:00 pm to, consider, approve and take on the record the Audited Financial Results for the quarter and year ended 31st March, 2021.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..